5 research outputs found
Additional file 1: of Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study
Table S1. Baseline third drugs in patients who switched to triple, dual, or monotherapy. (DOCX 12 kb
The scatterplot of baseline HIV-1 DNA levels and change between EOT and baseline.
<p>The scatterplot of baseline HIV-1 DNA levels and change between EOT and baseline.</p
Phylogenetic tree of HIV-1 C2V5 nucleotide clonal sequences of subject #53 during DAA therapy.
<p>The viral sequences at the various time points are indicated by different colours, see table insert. Bootstrap values ≥80% are indicated. Bars indicate p distance scale. In the insert mean diversity (number of nucleotide substitutions/site) of the sequences detected at different time points is reported.</p
Factors associated with increase of HIV-1 DNA (≥0.5 log<sub>10</sub> copies/million PBMC) at EOT when compared to baseline at univariable and multivariable analysis.
<p>Factors associated with increase of HIV-1 DNA (≥0.5 log<sub>10</sub> copies/million PBMC) at EOT when compared to baseline at univariable and multivariable analysis.</p
Median PBMC-associated total HIV-1 DNA at baseline, EOT and 3 months after DAA in OVC and SVC.
<p>Median PBMC-associated total HIV-1 DNA at baseline, EOT and 3 months after DAA in OVC and SVC.</p